Early research (Phase 1)Study completedNCT00003588What this trial is testingGene Therapy in Treating Patients With Ovarian CancerWho this might be right forOvarian Cancer National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Looking for participantsNCT05983276What this trial is testingDecitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian CancerWho this might be right forOvarian Cancer Loyola University 40
Testing effectiveness (Phase 2)Ended earlyNCT00505661What this trial is testingLetrozole in Patients With Ovarian TumorsWho this might be right forOvarian CancerFallopian Tube CancerPeritoneal Cancer M.D. Anderson Cancer Center 16
Not applicableUnknownNCT05458973What this trial is testingCirculating Tumor DNA and BRCA Reversion Mutation in Advanced or Recurrent Ovarian Cancer Patients With Germline Mutation.Who this might be right forOvarian Cancer Yonsei University 100
Testing effectiveness (Phase 2)Study completedNCT01472783What this trial is testingVeliparib Monotherapy for Relapsed Ovarian Cancer With BRCA MutationWho this might be right forRecurrent, Epithelial Ovarian Cancer Vejle Hospital 49
Large-scale testing (Phase 3)Active Not RecruitingNCT02502266What this trial is testingTesting the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian CancerWho this might be right forFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Serous Adenocarcinoma+12 more National Cancer Institute (NCI) 582
Testing effectiveness (Phase 2)Study completedNCT00510653What this trial is testingGleevec Study for Patients With Ovarian CancerWho this might be right forOvarian Cancer M.D. Anderson Cancer Center 73
Testing effectiveness (Phase 2)UnknownNCT04887961What this trial is testingReprab Study: PLD + Trabectedin RechallengeWho this might be right forRelapsed Ovarian Cancer Fondazione Policlinico Universitario Agostino Gemelli IRCCS 64
Testing effectiveness (Phase 2)Study completedNCT00003173What this trial is testingHigh-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid TumorsWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+5 more Memorial Sloan Kettering Cancer Center 36
Testing effectiveness (Phase 2)UnknownNCT05325229What this trial is testingDocetaxel for Injection (Albumin-bound) in Combination With Bevacizumab in Patients With Ovarian CancerWho this might be right forPlatinum-resistant Recurrent Ovarian Cancer CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 94
Early research (Phase 1)Not Yet RecruitingNCT06846424What this trial is testingSCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian CancerWho this might be right forOvarian CancerFallopian Tube CarcinomaPeritoneal Carcinoma Shanghai Gynecologic Oncology Group 24
Testing effectiveness (Phase 2)WithdrawnNCT05672095What this trial is testingNiraparib and Selenium for the Treatment of Recurrent BRCA Negative Platinum Resistant Ovarian CancerWho this might be right forPlatinum-Resistant Fallopian Tube CarcinomaPlatinum-Resistant Ovarian CarcinomaPlatinum-Resistant Primary Peritoneal Carcinoma+3 more City of Hope Medical Center
Early research (Phase 1)Study completedNCT00003967What this trial is testingTopotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube CancerWho this might be right forFallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer Gynecologic Oncology Group 24
Testing effectiveness (Phase 2)WithdrawnNCT00005645What this trial is testingILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous TreatmentWho this might be right forFallopian Tube CancerMetastatic CancerOvarian Cancer+1 more Genzyme, a Sanofi Company
Early research (Phase 1)WithdrawnNCT00118300What this trial is testingCapecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic CancerWho this might be right forCervical CancerEndometrial CancerOvarian Cancer+1 more Case Comprehensive Cancer Center
Early research (Phase 1)Looking for participantsNCT06305299What this trial is testingAutologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T CellsWho this might be right forOvary NeoplasmOvarian CancerEpithelial Ovarian Cancer+1 more UNC Lineberger Comprehensive Cancer Center 27
Early research (Phase 1)Study completedNCT00473954What this trial is testingSafety and Efficacy of EGEN-001 Combined With Carboplatin and Docetaxel in Recurrent, Platinum-Sensitive, Ovarian CancerWho this might be right forOvarian Neoplasms EGEN, Inc. 13
Testing effectiveness (Phase 2)Study completedNCT01610206What this trial is testingStudy of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian CancerWho this might be right forOvarian CancerFallopian Tube CancerPeritoneal Cancer Linda R Duska 148
Testing effectiveness (Phase 2)WithdrawnNCT00085527What this trial is testingFR901228 in Treating Patients With Relapsed or Refractory Advanced Ovarian Epithelial CancerWho this might be right forOvarian Cancer University of Chicago
Not applicableLooking for participantsNCT05446545What this trial is testingBespoke ctDNA Assay for Recurrence and Treatment Response Monitoring in Advanced Epithelial Ovarian CancerWho this might be right forOvarian Cancer Fudan University 139